InvestorBrandNetwork (IBN) Content Platform

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was quoted as a cybersecurity expert in a recent IT Brew article. A cybersecurity services company, SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. Titled “How to Keep Access-Control Under Control Amid Layoffs,” the article discussed the importance of maintaining control over who has admin access to a company’s key IT during layoffs and restructurings. The article noted that when employees are terminated, it is sometimes unclear whether they’ve relinquished their access privileges before they leave the building. The article pointed out that a number of strategies existed to help companies prepare for the risks that can occur when people with administrator privileges are deprovisioned; some of those strategies include consolidated access controls, visibility tools and isolated offboarding practices. In the article, Haugli recommends the “easy” shutdown method: Put the person in a room with HR, away from devices, while others dismantle access, lessening the chance of data leaks caused by insider ire. “That’s when you don’t want to screw up—when you’re letting an admin go, for whatever reason, and those people will literally have the ability to take down your production, your business, whatever it is that you hold dear to your organization,” said SideChannel CEO Brian Haugli in the article. “With a remote-heavy world now, this is proving a little bit more difficult to navigate, but not undoable.”

To view the full article, visit https://ibn.fm/XYBo1

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Aircraft design and manufacturer CubCrafters builds modern backcountry aircraft, carrying on the legacy of historic Cub-style Aircraft, offering FAA-certified, light sport, and Experimental category airplanes. Aside from new aircraft produced on the production line, the company also offers aircraft produced under the company’s builder-assist program, and kits for those prepared to build on their own
• CubCrafters applied for Reg A+ status in July in an effort to raise public investment toward accelerating the company’s growth and production schedule output
• The company’s CEO and president announced recently that the SEC has qualified CubCrafters’ application, opening the way for interested investors to now come onboard
• One of the aircraft’s primary uses has been for backcountry exploration and recreation, but the American-made company was also lauded recently for helping a missionary in remote Mexico fly rural patients to the city for needed medical care

Best-in-class backcountry aircraft producer CubCrafters unveiled its plans to offer shares to the public with its announcement in July that the company was accepting reservations for preferred stock under a Reg A+ filing.

CubCrafters President and CEO Patrick Horgan recently provided an update on the filing, announcing in a Bell2Bell podcast that the U.S. Securities and Exchange Commission (“SEC”) has qualified the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has announced that its flagship certified CC19 XCub aircraft was recently selected by the United States Department of Agriculture (“USDA”) for a new government aircraft fleet modernization contract. Since 2003, CubCrafters has supplied the U.S. government with aircraft that have been used by various agencies to complete missions in some of the most remote and extreme flying environments. Manufactured under this most recent contract will be the first certified XCub in fleet service with the U.S. government and will be primarily used for natural resources management. Delivery of the first two aircraft in the multiyear contract is scheduled for the late summer of 2023. “Our long relationship with the U.S. government is a strong testament to our ability to design and manufacture exceptionally rugged utility aircraft for backcountry missions,” said Patrick Horgan, CubCrafters’ president and CEO. “This contract is not only important for us as a supplier for the U.S. government, but also for investors participating in our ongoing public offering. This sale demonstrates that our newest generation of fully certified modern utility aircraft can replace the aging fleet of legacy aircraft now in service. It shows that there is a very bright future for our fleet sales program.”

To view the full press release, visit https://ibn.fm/xhvUK

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Stemtech (OTCQB: STEK), an innovative stemceutical(TM) company and a pioneer in the field of stem cell nutrition, has introduced its new CellectOne(TM) innovative and cutting-edge skincare line; Stemtech also launched the first offering in the product line: the Rapid Renew Stem Cell Peptide Night Cream. Stemtech is partnering with Life Factor Research to create product lines designed to build a dedicated and naturally expanding following. This new product line and initial product offering is the foundation of that strategic plan. “Introducing a new product is always a significant mark of advancement,” said Stemtech Corporation president and COO John W. Meyer in the press release. “This new branding of the Stemtech Corporation stem cell skincare line under brand CellectOne is a great step forward. The strategic vision of Stemtech continues to become reality with the Life Factor Research contributions of new cutting-edge science and technology. We are proud to introduce the first of many new products to come. CellectOne products are developed by Stemtech’s new Research and Development Division, Life Factor Research. The science and technology used to create the Rapid Renew Stem Cell Peptide Night Cream is a tremendous, all-natural, ingredient-based product which penetrates deeply into the skin layers for improving skin health.”

To view the full press release, visit https://ibn.fm/2BGNg

About Stemtech Corp.

Stemtech Corporation, a leading stemceutical company with a direct-sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International Inc., which was established in 2005. From 2010 through 2015, Stemtech International Inc. was recognized four times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company and has expanded business opportunities for its independent business partners, who may earn incomes by sharing Stemtech products. The company markets its products under the following brands: RCM System, stemrelease3(TM), Stemflo(R) MigraStem, OraStem(R) (Oral Health Care), CellectOne (skincare products) and D-Fuze(TM) (EMF blocker). Its stemceutical products are all natural, plant based and manufactured under Current Good Manufacturing Practices under the auspices of the Dietary Supplement Health and Education Act. For more information about the company, please visit www.Stemtech.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Global Strategic Management Institute (“GSMI”), a cutting-edge conference production company focused on promoting disruptive innovation, today announced its plans to host the upcoming Social Media Strategies Summit Public Agencies and Government Virtual Conference. The two-day event will be held in an entirely digital format on Dec. 7-8, 2022, and feature 15 highly informative sessions. Experienced speakers and dynamic industry veterans will offer insight on a radically fresh perspective on social media strategy targeted towards benefiting public agencies and government bodies. The flagship event caters to professionals working in public agencies at varying levels of government, global governance and policy analysis, and offers a comprehensive social media education experience and a world-leading platform to network with industry peers from around the world.

To view the full press release, visit https://ibn.fm/cpkJC

About Global Strategic Management Institute (“GSMI”)

GSMI is a conference production company based in San Diego and San Francisco, with a footprint in over 100 countries. Reaching more than 92% of Fortune 500 companies, GSMI has been named one of San Diego’s Top 100 Emerging Companies for multiple years. GSMI events are known for sparking imagination as attendees are introduced to the tools that will take their careers to the next operational level. For more information about the company, visit www.GSMIWeb.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TRxADE Health (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, announced that Bonum Health, its digital healthcare business subsidiary, has signed a preferred telemedicine services agreement with an independent group purchasing organization. The agreement outlines significant discounts for group members to access Bonum Health’s service platform of more than 100 pharmacies in the northeastern part of the United States. “We have seen an increase in interest among the independent pharmacy community who are looking to diversify their service offerings to patients by providing affordable access to telehealth solutions for the growing uninsured and underinsured patient population,” said TRxADE Health chief clinical and compliance officer Dr. Shafaat Pirani, PharmD, BCGP, in the press release. “In most states, pharmacists are not recognized as providers with prescriptive authority, and must therefore submit medication recommendations to the prescriber, which often leads to delays in therapy which may lead to adverse outcomes for patients. The ability to connect a patient with a telemedicine provider using our mobile application, for a simple medication refill or to prescribe an acute course of antibiotics or steroids for an infection, is the type of convenience we believe patients are seeking in today’s digital environment.”

To view the full press release, visit https://ibn.fm/Y1KLq

About TRxADE Health Inc

TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 14,000 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Trace, an emerging impact-driven and women-owned brand, today announced the upcoming launch of the world’s first-ever fully traceable, patent-pending, Climate Beneficial(TM) cotton and regenerative hemp fiber tampon. A petroleum-free alternative, Trace Tampons actively sequester carbon, addressing plastic pollution and global warming, two critical challenges that plague the disposable period care industry. Trace’s founder and CEO Claire Crunk, a women’s health nurse practitioner and mother of three daughters, knew that, upon learning about ingredients like “dioxins and furans” (known carcinogens and endocrine disruptors) commonly found inside essential period care products, she had to lead the initiative to find a solution. A pioneer in U.S. hemp fiber production, Crunk spent two years nurturing key relationships and building a robust supply chain to produce the hemp that would eventually create Trace’s regenerative Climate Beneficial care line. “Organic cotton and plastic-free are great, but we wanted to push the limits to give women something even better. Not only are we technically exceeding organic standards, but our innovations empower women to help reverse climate change simply by having a period and using our tampons,” said Crunk. “It’s not enough to simply be organic anymore. Regenerative is the new eco-friendly economy and the future of sustainable agriculture; these aren’t simply ideas or marketing slogans. We are acting in innovative ways never before seen in the industry.”

To view the full press release, visit https://ibn.fm/hYXDg

About Trace Femcare

Based in Nashville, Tennessee, Trace is a purpose-driven company on a mission to heal the earth and nurture bodies. The company’s board and founders are made up of multiple health care providers and a top engineer specializing in absorbent hygiene, along with the hardworking hands of trusted farmers. Trace is ensuring its tampons will go well beyond sustainability and foster regeneration of healthy soil while surpassing traditional organic standards. To invest in Trace and view a short video on the company’s philosophy and WeFunder campaign, visit: https://wefunder.com/trace.tampons.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has received Fast Track designation from the U.S. Food and Drug Administration (“FDA”) for the development of its proprietary investigational nasal spray: PH10. The designation can expedite development of PH10 as a potential treatment of major depressive disorder (“MDD”) in adults. The FDA designation enables accelerated development and review of new drugs that show potential to address unmet medical needs and are designed to treat serious or life-threatening conditions. PH10 is an investigational pherine nasal spray with a potential rapid-onset mechanism of action (“MOA”) that is differentiated from the MOA of approved treatments for depression disorders. “Vistagen is laser focused on bringing an innovative treatment option to individuals suffering with debilitating depression,” said Vistagen CEO Shawn Singh in the press release. “The FDA’s grant of the Fast Track designation for the development of PH10 in major depressive disorder is a significant regulatory milestone, aligned with our belief in PH10’s potential to improve the standard of care in a significant market where new and differentiated treatments are urgently needed. Nearly two-thirds of diagnosed and treated depression patients do not achieve remission with a first line therapy. With 21 million adults in the U.S. suffering at least one major depressive episode in the past year, potentially millions of individuals are not getting the help they need. We look forward to working with the FDA’s Fast Track program as we advance development of PH10 in the United States.”

To view the full press release, visit https://ibn.fm/HrDDP

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage CNS-focused biopharmaceutical aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression — one mind at a time. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and nonalcohol beverages, is reporting its financial and corporate results for the third quarter ended Sept. 30, 2022. Highlights of the report include total revenue for the quarter totaling $3,162,422, which is up $315,985 from the same quarter in 2021, and cash on hand at the end of the quarter reaching $2,798,401, an increase from numbers reported Dec. 31, 2021. Corporate highlights include the launch of Pop Top Naturals Juice Pouches, a healthy, portion-controlled box designed to be a solution for the kid’s juice box space, and the premiere of Bellissima Zero Still Wines on QVC. In addition, the company has doubled its production capacity; Iconic now has the capacity to produce 80 million product units, with those products including frozen ice pops, various stand-up flexible pouches, single-serve shots, organic juice pops and dog treats in 2022. “Historically, TopPop’s second half of the year has represented our ‘softest’ from a revenue perspective, since the traditional frozen cocktail market is highly seasonal,” said Iconic Brands interim CEO Tom Martin in the press release. “It is also the part of the year that we typically book new business and prepare to manufacture for deliveries in the first quarter. Because we are a fast-growing business, this has an effect on our operations as we develop new product categories and broaden our customer base to even out this inconsistency in our quarterly results. . . . However, our bookings are strong, and our business is expanding into new areas while we continue to demonstrate our growth trajectory and commitment to building a platform of solutions within the industry. We believe that during this quarter, the fruits of our labor and investments began to pay off, as our production facilities made great progress with the ready to freeze, ready to drink ice pops and pouches.”

To view the full press release, visit https://ibn.fm/QcOcN

About Iconic Brands Inc.

Iconic Brands, together with its wholly owned subsidiary, TopPop, develops brands, innovates products and creates sustainable packaging solutions for the alcohol and nonalcohol beverage market. Iconic offers a collection of brands in the wine & spirits, ready-to-drink cocktail, ready-to-freeze ice pop, and premixed ready-to-go categories. In addition, TopPop offers turnkey solutions, from design to delivery, in sustainable packaging for major alcohol and nonalcohol beverage and frozen food brands. Iconic prides itself on its commitment to brand expansion and to delivering purpose-driven brands that strive to lead the change in the “Better-for-You” and “Better-for-the-Planet” categories. In July, Iconic announced its intention to change its name to TopPop Innovative Brands to better reflect the focus and fundamental drivers of the business. Iconic operates in multiple states, with worldwide distribution and a number of Fortune 500 customers, including some of the world’s largest alcohol beverage companies and brands. For more information about the company, please visit www.IconicBrandsUSA.com and www.TopPopPkg.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

RYAH Group (CSE: RYAH) today announced the appointment of Tanvir Malik Mukhtar, who brings two decades of experience working in leading financial institutions, as a member of its board of directors. “I have personally known Tanvir since 2015,” said RYAH’s Chief Executive Officer Dr. Dave Richards. “I’m highly confident that her enormous talent, intellect, leadership, entrepreneurial qualities, experience, and network will bring immense value and perspective to our board, and massively contribute to RYAH’s journey and success.” Mukhtar’s appointment follows the resignation of Dr. George Anastassov, who is leaving for personal reasons after serving on the board for nearly three years. The company would like to thank him for his services and wish him the best of luck in his future endeavors.

In addition, the company announced that, on Nov. 25, 2022, it filed on SEDAR the audited financial statements to Dec. 31, 2021, together with the respective management discussions and analysis and CEO and CFO certificates. RYAH is currently finishing the preparation of the first three quarterly financial statements for 2022, together with their respective MD&A documents. The company plans to soon file these financial statements and documents on SEDAR and will then promptly apply for a revocation of the Cease Trade Order, which should lead to a resumption of trading of its shares on the Canadian Securities Exchange.

To view the full press release, visit https://ibn.fm/chTS4

About RYAH Group Inc.

RYAH is a global big data and cannabis and other nutraceutical delivery technology company enabling valuable AI-powered predictive analytics of the efficacy of plant-based medicines and other substances administered through its IoT-connected devices. These include the world’s only Smart Inhaler(TM) and Smart Patch(TM).

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA) (TSX.V: SIM), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, is continuing to expand its distributor network. The company announced that it has added RadioTrader, the United Kingdom and Ireland’s premier two-way radio supplier, as a supplier of its SD7 ruggedized, mission-critical PoC device and VK7 vehicle kit accessary. Radio Trader services customers in agriculture, aviation, education, retail, hospitality, oil and gas, marine, and recreation and sport sectors, and has been providing PoC devices for some time. A representative noted that mission-critical devices are a key component for the company, which was extremely impressed with the SD7 and its audio quality, build quality, signal strength and ability to perform even in remote areas. “Buyers from a wide variety of industries rely on RadioTrader and its more than 20 years of industry experience for two-way radio solutions,” said Siyata CEO Marc Seelenfreund in the press release. “As a premier supplier in the UK and Ireland, adding the SD7 device and VK7 vehicle kit to their offering is yet another validation of the quality of our products and could lead to near-term sales opportunities. The SD7 is the perfect upgrade from LMR devices, which often have limited coverage, restricted functionality, and high startup costs. Our SD7 solves all those problems, delivering a far superior solution to a multi-billion industry.”

To view the full press release, visit https://ibn.fm/isWXj

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation Push-to-Talk over cellular (“PoC”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Siyata’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Social Media Strategies Summit (“SMSS”) for public agencies and the government will be held as a virtual conference on December 7-8, 2022. As SMSS brings in 10 years of education in the social media realm, this is a must-visit event for government agencies to connect and engage with their different communities. The SMSS is a distinguished industry event attended by eminent social media dignitaries who share their expertise, knowledge and insights with an equally engaging and interactive audience.

Important discussion topics for the panel include how to build a framework for your brand voice & tone. Social media influencers will talk about how agencies can find their voice by finding a balance between important professional content and encouragement of a positive and enjoyable…

Read More>>

To learn more, please visit (https://ibn.fm/0juYB).

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Hero Technologies (OTC: HENC), a cannabis company focused on a seed-to-sale vertical integration strategy, today announced that it has closed on the purchase of a 10-acre property in Vassar Township, Michigan; HENC is purchasing the property for the purpose of growing, processing and selling cannabis. The transaction included a $75,000 down payment on the $600,000 property; the company anticipates paying off the loan within five years. According to the announcement, zoning for the property supports Hero Technologies licenses to produce and market marijuana for both medicinal and adult recreational use. Specifically, Hero Technologies’ subsidiary BlackBox Systems and Technologies LLC, has prequalification approval for adult and medicinal use cannabis licenses; BlackBox also recently received approval to use the newly purchased property for cannabis operations. The company noted that more than 1.6 million people live within 50 miles of the property, which is a 1.5-hour drive from Lansing, the state capital, and Detroit, with a metro population of 4.4 million. “We are gratified to be able to close on our target property in Vassar, Michigan, according to plan,” said Hero Technologies CEO Gina Serkasevich in the press release. “We chose the site for its cannabis-friendly local zoning, cost effectiveness, and geographic location at the heart of Michigan’s booming marijuana market. We are acting promptly to develop the property for cannabis production under our state and local licenses, and we look forward to generating a positive return on our investments for our employees and our investors.”

To view the full press release, visit https://ibn.fm/S91Xj

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator (“MSO”). For more information about the company, please visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, today announced completion of all necessary agreements with LANXESS Corporation to secure access to the proposed commercial lithium plant site (the “site access agreement”) and all required fieldwork to support the Definitive Feasibility Study (“DFS”) underway. In addition, the company announced that subsequent to entering the site access agreement, it has commenced the site work necessary for the design of its first commercial lithium plant. “The company is pleased to reach this important milestone. Our team has successfully negotiated and agreed to a key agreement with LANXESS, the site owner, to exclusively secure the required property for our commercial facilities and allow us to start working on the ground at the proposed location of the first commercial lithium project,” said Dr. Andy Robinson, president of Standard Lithium. “The data gathered over the next few months will be vital to allow the OPD team to design the plant and locate key equipment on the large land area available to Standard Lithium at LANXESS’ South Plant facility. Once the important ground conditions are determined, and the location of key equipment can be fixed, then the engineering work to allow for connection between the Standard Lithium plant and LANXESS’ existing brine infrastructure present at the site can begin. We look forward to announcing more developments as the design towards the company’s first commercial lithium project unfolds.”

To view the full press release, visit https://ibn.fm/GI7Ww

About Standard Lithium Ltd.

Standard Lithium is a leading pre-commercial lithium development company with a portfolio of projects in process. The company’s flagship projects, the LANXESS Property Project and the South West Arkansas Project, are located in southern Arkansas near the Louisiana state line. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of unitized leases across these two projects. The company operates a first-of-a-kind industrial-scale Direct Lithium Extraction (“DLE”) Demonstration Plant at the LANXESS Property Project. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A Definitive Feasibility Study (“DFS”) and Front-End Engineering Study (“FEED”) for Phase 1A of the LANXESS Property Project commenced in September 2022. A Preliminary Feasibility Study (“PFS”) of the South West Arkansas Project commenced in May 2022. The company is also pursuing the resource development of approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• FinCEN reported 1,489 incidents of ransomware totaling close to $1.2 billion in 2021, a value that has doubled from 2020
• Key industries experiencing a high need for cybersecurity solutions include fintech, biotech, healthcare, manufacturing, legal defense, and technology services
• The global healthcare cybersecurity market is expected to reach $57.25 billion by 2030, growing at a CAGR of 16.3% from 2021 to 2030
• SMBs have experienced an increase in cybersecurity threats due to remote-based work and in-office workers depending on cloud-based solutions, mobile devices, software applications, and third-party suppliers to conduct business
• SideChannel’s goal is to make cybersecurity simple and accessible, offering a wide range of solutions to identify, evaluate, and tackle risks

In the United States, financial institutions are required to file suspicious activity reports to help the government detect money laundering or other criminal activities – including security breaches. The Financial Crimes Enforcement Network’s (FinCEN) analysis indicates that ransomware continues to pose a significant threat to the United States critical infrastructure sectors, businesses, and the public. In 2021, financial institutions filed 1,489 incidents related to ransomware – nearly $1.2 billion in likely ransomware-related payments, more than double the amount from 2020. According to FinCEN, the amounts within its analysis include extortion amounts, attempted transactions, and payments that were not made (https://ibn.fm/Jz58w).

SideChannel (OTCQB: SDCH) simplifies cybersecurity for mid-market companies. The company’s mission is to make cybersecurity simple and accessible, based on a belief that small and mid-sized organizations (“SMBs”) deserve the expertise of an experienced Chief Information Security Officer (“CISO”) just as…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has appointed a new board member; Matthew J. Hawryluk, PhD, will “help support the company’s strategic initiatives and commercialization efforts.” A well-known business executive in the pharma and biotech industries, Hawryluk currently serves as executive vice president and chief business officer of Gritstone bio, Inc. (NASDAQ: GRTS). Prior to moving to Gritstone, Hawryluk filled a variety of business-development, marketing and product-management roles, including VP of corporate and business development at Foundation Medicine Inc., a public molecular information company, which was subsequently acquired by Roche. Hawryluk has been instrumental in bridging the gap between scientific discovery and the commercial application of scientific breakthroughs. He is a named inventor on multiple patents and has coauthored several peer-reviewed publications. “Given his deep understanding of the biopharma landscape and his years of experience launching innovative platforms that have now been run on hundreds of thousands of patients with more than 20 FDA approvals, Matthew is both a logical and strategic addition to our Board,” said Predictive Oncology CEO and board chair Raymond F. Vennare in the press release. “In the business of drug discovery, relationships, reputation and industry reach are invaluable attributes, all of which Matthew possesses.”

To view the full press release, visit https://ibn.fm/oiDU4

About Predictive Oncology Inc.

Predictive Oncology is a knowledge-driven company focused on applying artificial intelligence (AI) to develop optimal cancer therapies, which can lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses a biobank of 150,000-plus cancer tumors, categorized by patient type, against drug compounds to help the drug-discovery process and increase the probability of success. The company offers a suite of solutions for oncology drug development from early discovery to clinical trials. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for all of North America, has published a new interview with its Chief Financial Officer Channing Chen. During the interview, Chen discussed his journey to the clean tech space and Correlate, as well as his focus in his role as CFO, both in the immediate future and the long term. “Our shareholders are our most important constituents, and I try to make sure our day-to-day activities drive meaningful enterprise value while ensuring we are compliant on all fronts as a publicly traded company working on an eventual uplist to the NASDAQ. At a tactical level, managing cash flow is a constant priority, especially for an infrastructure business like ours, to ensure there is sufficient capital to grow the business optimally – whether by organic growth or acquisitions. Another critical focus area is finding, hiring and retaining good people, who can be strategic thinkers, understand the value of process, are not afraid of technology, and can get things done efficiently,” Chen said. “Our business is definitely less about sitting in meetings and more about execution. It is an exciting time to be in our industry, so we are hoping to attract stellar talent to complement our team. Longer term, it is all about optimization and doing things more efficiently and more cost effectively than any other company in our sector without compromise. None of this is rocket science with the right people in place.”

To view the full interview, visit https://ibn.fm/mDfNS

About Correlate Infrastructure Partners Inc.

Correlate Infrastructure Partners is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. The company’s integrated solutions include solar, cogeneration, energy storage, electric vehicle infrastructure and intelligent efficiency retrofits for community-scale applications. Correlate reduces costs, improves comfort and increases energy reliability for home, work and commerce while eliminating the adoption barriers to net-zero carbon goals. For more information, visit the company’s website at www.CorrelateInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) is a Worcester, Massachusetts-based company committed to creating top-tier cybersecurity programs for small and midsize businesses (“SMBs”) to help them protect their data and assets. This comes as reports show that cyberattacks on SMBs have increased in recent years. “SideChannel simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time chief information security officer (‘CISO’). SideChannel’s team of virtual CISOs possesses combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank, and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise,” a recent article reads. The company also offers Enclave, which “expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool. A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency, and strengthen overall security defense.”

To view the full article, visit https://ibn.fm/dBx6Y

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients. Learn more at SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services, was featured in a new episode of the Stock Day Podcast. PBI’s CEO Richard T. Schumacher joined Stock Day host Everett Jolly to explain and highlight important recent developments and progress with the company’s Ultra Shear Technology(TM) (UST(TM) or UltraShear(TM)) platform. “We have established ourselves as the leading innovator in harnessing extreme-pressure processing and transformations of materials routinely and safely. We now have 30 issued patents across our platforms, with seven of them secured around our unique UltraShear platform, which combines ultra-high pressure with very intense liquid shearing forces – to, quite simply, make oil effectively and stably dissolve into water for vastly improved speed and effectiveness in delivery of benefits,” Schumacher said. “We are literally now producing our first batch of an oral spray CBD product, with pilot production underway and shipping to follow in the first week or so of December – meeting our announced fourth quarter objective of making and selling our first commercial UltraShear product. The markets that UltraShear addresses span an enormous universe of oil-based active ingredients, including CBD, but also ingredients like vitamins, antioxidants, foods, pharmaceuticals, and more.”

To view the full press release, visit https://ibn.fm/XAJim

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) patented technology from BaroFold Inc. (the BaroFold technology) that allows entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sustainable Green Team (OTC: SGTM), an industry-leading wholesale manufacturer and supplier of consumer and industrial wood-based mulch, soil, and lumber products nationwide, is now trading on OTCQX Best Market. The company announced that the change in exchange is effective today; moving to the market is an important milestone and demonstrates the Sustainable Green Team’s ability to meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. According to the announcement, the ticker symbol for the company will remain the same: SGTM. The change in markets will enable potential investors to research and trade company shares. “Joining the QTCQX Best Market is an important milestone for our company,” said the Sustainable Green Team CEO Tony Raynor in the press release. “Our team has worked hard to meet the requirements and criteria to qualify, and we will continue to hold ourselves to the highest regulatory and compliance standards. We believe that the broader exposure afforded by this change to a higher tier market will raise our visibility within the investment community and assist in increasing the liquidity of our common stock and ultimately create shareholder value.”

To view the full press releases, visit https://ibn.fm/P9RZo and https://ibn.fm/UwyWi

About Sustainable Green Team Ltd.

The Sustainable Green Team is a wholesale manufacturer and supplier of wood-based mulch, soil and lumber products, selling directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores and food stores, in addition to wholesalers and distributors. The company also provides arbor care and storm-recovery services at the residential, commercial and municipal levels while offering green-waste solutions to large- and small-scale waste disposal and recycling companies located throughout the southeastern United States. The company’s subsidiary, Mulch Manufacturing Inc., is the largest provider of cypress mulch in the country. SGTM has entered into an agreement with Australia-based VRM Biologik Group to bring VRM’s world-leading, soil-moisture technology to the Unites States at scale. HumiSoil(R) and XLR8 Bio(R) are soil-treatment products that rebuild soil hydration on a cellular level, improving the soil and the vegetation and agricultural products it supports. The company plans to make HumiSoil and XLR8 Bio available for home gardens and lawns throughout the U.S. to help relieve water use in cities as well as to help VRM Biologik Group in its mission to restore productivity in depleted topsoil in 25% of the world’s arable land. For more information about the company, please visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage Group (NYSE American: SBEV) was featured in a recent interview with Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies. Splash’s CEO and Chairman Robert Nistico joined Traders News Source Senior Editor Mark Roberts in a C-level interview to discuss an overview of the company, segments, revenue streams, Q3 earnings report, and how building the TapouT brand is different from building the Red Bull brand. The interview also shared insight on the biggest potential near-term catalysts for shareholders plus much more.

To view the full press release, visit https://ibn.fm/ZrkxQ

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a software-as-a-service (“SaaS”) technology company delivering innovative mobile live dealer technology to online gaming operators globally, today announced that all six director nominees proposed in its management information circular dated Nov. 7, 2022, were elected at the company’s annual general and special meeting of shareholders (“AGM”). Directors James Penturn, Darcy Krogh, Guido Ganschow, Michele (Mike) Marrandino, William Scott and Robert J. Soper will serve until the next AGM or until their successors are duly elected or appointed, unless such office is earlier vacated in accordance with the company’s articles. Playgon Games also announced that D&H Group LLP was reappointed as independent auditor of the company and that its shareholders re-approved the company’s 10% “rolling” stock option plan.

To view the full press release, visit https://ibn.fm/Ofk9b

About Playgon Games Inc.

Playgon Games is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, the company’s products are ideal turn-key solutions for online casinos, sportsbook operators, land-based operators, media groups, and big database companies. For further information, please visit the company’s website at www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that it will present at the upcoming RHK 2022 Disruptive Growth Conference taking place at the offices of Reed Smith in New York City on Dec. 5-6, 2022. Catherine Vaczy, Genprex’s EVP, general counsel and chief strategy officer, will be providing an overview of the company’s gene therapies for cancer and diabetes. Vaczy’s presentation is slated to begin at 2:40 p.m. ET on Tuesday, Dec. 6. In addition, Vaczy will be available for a question-and-answer period following the presentation and for in-person, one-on-one meetings with investors at the conference.

To view the full press release, visit https://ibn.fm/rLwZn

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express tumor suppressor proteins that are deficient in the body. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”) (with each of these clinical programs receiving a Fast Track Designation from the Food and Drug Administration) and for small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes to the pancreas. In models of type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In type 2 diabetes, where autoimmunity is not at play, it is believed that exhausted beta cells are also rejuvenated and replenished. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Lottery.com’s (NASDAQ: LTRY) wholly owned subsidiary Sports.com Inc. working with the Saudi Motorsport Company (“SMC”) for the establishment of a joint venture and content distribution partnership; the announcement of the partnership coincides with activity surrounding the FIA World Touring Car Cup decider, which was held in Saudi Arabia on Nov. 23–27, 2022.  That activity included Sports.com branding and advertising being displayed around the track during the competition. A new sports entertainment platform with both online and offline offerings, Sports.com is committed to becoming the world’s foremost locale for sports entertainment. The platform will enable fans to watch a variety of sports in every country, in any language, and on any device, either live or on demand. In addition, Sports.com will provide data, insights and information along with e‐gaming, education, ticketing, and merchandising services; bringing together fans with athletes, franchises, teams, rights owners, gaming providers, sponsors and advertisers. Founded by the Saudi Automobile and Motorcycle Federation (“SAMF”), SMC is a state-owned and funded company that works to bring all Saudi activity in the sector under a single entity. SAMF is the first public body designed to commercialize motorsport at a national level in the Saudi. Lottery.com is the world’s leading provider of lottery results data servicing global publishers, search engines, and voice assistants. “We are honored that Sports.com is partnering with the Saudi Motorsport Company, in what we trust will be the first of many opportunities,” said Lottery.com chair and president of Sports.com Matthew McGahan in the press release. “Our branding around the track was visible to fans in attendance and to millions of viewers around the world, in over 150 countries, where the race was broadcast and free to view. In addition, Sports.com’s branding was also reflected on Ahmed BinKhanen’s Audi GT car. BinKhanen is one of the kingdom’s best driving talents. Saudi Motorsport Company sees the potential to partner with our new platform, which we believe will revolutionize fan viewing and interaction within the fast‐changing sports entertainment industry, and we look forward to concluding further similar agreements around major sporting events with broadcasters and rights owners around the world.”

To view the full press release, visit https://ibn.fm/IVIEc

About Lottery.com 

Lottery.com is a leading technology company that is transforming how, where and when lottery is played. Its engaging mobile and online platforms enable players and commercial partners located in the United States and internationally to remotely purchase safe and legally sanctioned lottery games. Lottery participants look to Lottery.com for compelling, real-time results on more than 800 lottery games from more than 40 countries. Additionally, through WinTogether.org, Lottery.com is fundamentally changing how nonprofit donors are incentivized to action by gamifying charitable giving. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• DSN recognized The Happy Co. CMO with a Bronze Stevie award in its Women of the Year — Business Services category
• New MojiLife president has 20-plus years experience in direct-sales space
• SHRG is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies

Key leaders in the Sharing Services Global (OTCQB: SHRG) family have captured the spotlight recently. Clare Holbrook, chief marketing officer of The Happy Co., was honored with a Woman of the Year Award by Direct Selling News (https://ibn.fm/RNB8R), and Kristine Widtfeldt was named president of MojiLife, a leader in the direct-selling fragrance sector (https://ibn.fm/jqXDR). SHRG has an ownership interest in both companies.

Direct Selling News (“DSN”) announced last week that Holbrook was recognized with a Bronze Stevie Award in its Women of the Year — Business Services category. “This Stevie Award honors outstanding women executives, entrepreneurs, employees and the companies they lead,” the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sachem Capital (NYSE American: SACH) specializes in originating, underwriting, funding, servicing, and managing a portfolio of first mortgage loans. It offers short-term (i.e., three years or less) secured, non­banking loans (sometimes referred to as “hard money” loans) to real estate investors to fund their acquisition, renovation, development, rehabilitation, or improvement of properties located primarily in Connecticut. The company does not lend to owner occupants. The company’s primary underwriting criteria is a conservative loan to value ratio.

The properties securing the company’s loans are generally classified as residential or commercial real estate and, typically, are held for resale or investment. Each loan is secured by a first mortgage lien on real estate. Each loan is also personally guaranteed by the principal(s) of the borrower, which guaranty may be collaterally secured by a pledge of the guarantor’s interest in the borrower. The company also makes opportunistic real estate purchases apart from its lending activities. The company believes that it qualifies as a real estate investment trust (“REIT”) for federal income tax purposes and has elected to be taxed as a REIT beginning with its 2017 tax year. For more information, visit the company’s website at www.sachemcapitalcorp.com

To view IBN’s virtual coverage of Sachem Capital and other presenters at the RHK Capital 2022 Disruptive Growth Conference, visit https://ibn.fm/RHK2022DisruptiveGrowth

Institutional, family office and high-net-worth investors, as well as RIAs, who wish to schedule a 1×1 meeting with the company can contact the RHK conference team directly at [email protected]

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at the RHK Capital 2022 Disruptive Growth Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Sustain SoCal, a nonprofit organization, has joined with Roth Capital Partners to host the fifth annual Sustainability Private Capital Event. The virtual event is scheduled for Dec. 7–8, 2022. The premier gathering is designed to bring together investors from venture capital, private equity, family offices, endowments, foundations and angels with C-level executives from established private sustainability companies. The format of the event includes company quick pitches, one-on-one and small-group meetings, and industry panels. Roth is a founding member of Sustain SoCal. “With the recent landmark passing of the Inflation Reduction Act (‘IRA’) and the Infrastructure and Jobs Act, private companies within the sustainability sector are set to experience a renaissance,” said Roth managing director of sustainability investment banking Jesse Pichel in the press release. “The IRA incentivizes renewable energy deployments and incentivizes onshore manufacturing in the USA. The deployment of capital coming in the form of manufacturing and investment tax credits as well as loan guarantees is unprecedented and exceeds that of the Apollo Moon Program (on an inflation-adjusted basis). The push and pull incentives for sustainable companies will help mitigate common risks associated with private investing as investment dollars for sustainability continues to increase. Looking to facilitate private company investments, we have curated a robust group of private companies across the sustainability industry.”

To view the full press release, visit https://ibn.fm/jeNA3

About Sustain SoCal

Sustain SoCal, a nonprofit organization, accelerates sustainability and economic growth through innovation, collaboration and education in southern California. The organization has a 10-year history in exploring and implementing pragmatic, real-world solutions to the challenges created by growth, change and inefficiency. It conducts conferences, workshops and networking events that lead to initiatives that positively impact our region’s economic progress and sustainability. For more information, visit the company’s website at www.SustainSoCal.org.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the only provider building both annealing and gate-model quantum computers, has announced that it will host its annual global Qubits Conference in Miami on Jan. 17-19, 2023. In its seventh year, Qubits is differentiated by its focus on real-world applications of quantum technology that can deliver business value today. Qubits 2023 will feature demos of real-world quantum hybrid applications, updates on D-Wave’s technology product roadmap, guidance from practitioners and industry analysts, and quantum programming tutorials to highlight how quantum computing can drive business impact.

“Quantum computing has moved from the lab to the boardroom, as organizations are increasingly utilizing quantum and quantum-hybrid technologies to solve today’s computationally complex business problems,” said Dr. Alan Baratz, CEO of D-Wave. “At Qubits 2023, we’re thrilled to reconvene in person once again, bringing together the ecosystem fueling this transformation for important dialogue that will highlight the latest in quantum products and research and deliver practical guidance on how to infuse quantum into the enterprise today. We’re proud to host this gathering of quantum’s trailblazers in Miami to further our collective mission of quantum computing innovation and adoption.”

To view the full press release, visit https://ibn.fm/VvRww

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including NEC Corporation, Volkswagen, DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory. For more information about the company, visit www.DWaveSys.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Brain Scientific (OTCQB: BRSF), a Florida-based applied science technology company, today announced a new distribution agreement with Fulcrum to drive sales. In addition, the company announced the appointment of Kevin Winterfield as vice president of marketing and communications to accelerate Brain Scientific’s strategic growth plan heading into the new year. “Brain Scientific is ready for rapid expansion after completing important milestones, including improving the NeuroCap(TM), achieving the CE Mark for sales in Europe, onboarding a strong manufacturing partner and signing distribution and sales rep partners,” said Hassan Kotob, CEO of Brain Scientific. “We are excited to have such experienced partners and colleagues joining our team at this critical moment in the company’s history.”

To view the full press release, visit https://ibn.fm/HBMRu

About Brain Scientific Inc.

Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of OEM devices. To learn more about Brain Scientific’s corporate strategy, products or investor relations, please visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today issued a letter to shareholders highlighting the company’s progress and potential for its portfolio of novel, IP-protected technologies and assets developed in collaboration with world-class medical research partners. “Our company, Silo Pharma Inc. (NASDAQ: SILO) is working diligently to make further advances in the medical and psychedelic space. To date, the research conducted has shown encouraging promise in the delivery, efficacy and safety of our pipeline therapeutics and technologies,” Silo Pharma’s CEO Eric Weisblum writes in the letter. “This has been an exciting year where we have achieved numerous milestones and anticipate upcoming updates as our pipeline progresses. The purpose of this letter is to provide shareholders with an update on our current business. With over $12 million in cash, we are prepared to advance our pipeline, and believe, with our strong balance sheet, no debt and recent listing on Nasdaq, that we are in a position to further advance the company and create shareholder value.”

To view the full press release, visit https://ibn.fm/i7uEO

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sigma Additive Solutions (NASDAQ: SASI), a leading provider of quality assurance software to the commercial 3D printing industry, today announced that it has joined the EOS Developer Network (“EDN”) by EOS, a leading supplier for responsible manufacturing solutions via industrial 3D printing technology. The move enables Sigma to provide software and analytics applications from EOS application programming interfaces (“APIs”). “This is a great step in allowing us to support customer quality at every point of their additive journey, as well as better integrate with other software solutions,” said Sigma’s General Manager of European Operations Stephan Kuehr. “EOS is a premier supplier to the entire additive manufacturing industry, including both metals and polymer technologies. We share their mission of providing high levels of manufacturing quality and economic sustainability. We believe that the combination of EOS’ machine platforms with Sigma’s pedigree in agnostic monitoring and analytics software will be a marketplace differentiator and catalyst for growth of the entire additive industry.”

To view the full press release, visit https://ibn.fm/W2sho

About Sigma Additive Solutions Inc.

Sigma Additive Solutions is a leading provider of in-process quality assurance (“IPQA(TM)”) solutions to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring and analytics known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing space, today announced that it has launched four models of iHEAR branded OTC Rechargeable Hearing Aids on CVS.com. The launch provides InnerScope with a much broader market penetration and distribution channel through CVS Health, the largest U.S. pharmacy chain. “The launch of iHEAR OTC Rechargeable Hearing Aids on CVS.com significantly bolsters the iHEAR brand and its market penetration,” said Matthew Moore, president and CEO of InnerScope. “Additionally, with this launch on CVS.com, we believe InnerScope, including its subsidiary, HearingAssist, currently has more distribution channels with retail locations than any other OTC hearing aid competitor.”

To view the full press release, visit https://ibn.fm/g4HNU

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com, HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite, SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will be launching soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022. The event is slated to take place on Dec. 6 – 8, 2022, with Dr. Chowdhury’s presentation starting at 9 a.m. ET on Dec. 7. Interested parties should visit https://ibn.fm/Zyyj9 to register for and access the presentation. Dr. Chowdhury will also be available for one-on-one investor meetings throughout the conference.

To view the full press release, visit https://ibn.fm/sA0Jd

About Nemaura Medical Inc.

Nemaura is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark approved Class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital health care subscription service that has been launched in the U.S. as a general wellness product as part of its BEAT(R) diabetes program that is currently undergoing pilot studies. The company sits at the intersection of the global type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023. For more information, visit the company’s website at www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that two employers selected Dario as part of an offering from a leading benefits brokerage partner. According to the update, the employers will deploy Dario’s solutions to help improve the cardiometabolic and musculoskeletal health of employees beginning in the first quarter of 2023. “Our partnerships are a core pillar of our growth strategy, and we are starting to see momentum building through those channels as the relationships mature,” said Rick Anderson, president of Dario. “The two new employer contracts add to our fast-growing segment of accounts utilizing Dario’s multi-chronic solution, and we are excited to realize more of these channel opportunities in the future.”

To view the full press release, visit https://ibn.fm/N2doe

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, is sharing an update on its efforts to seek marketing authorization from Medicines and Healthcare Products Regulatory Agency (MHRA) for Anti-TNF treatment of early-stage Dupuytren’s Contracture. ATNF officials, along with representatives from the company’s regulatory consultants from the United States and the United Kingdom, met with MHRA’s scientific advice committee for the second time in October. According to the announcement, 180 Life Sciences presented additional data to MHRA concerning the use of nodule size and hardness as surrogate markers relating to eventual finger contraction in Dupuytren’s disease; the company also asked MHRA officials a series of questions to MHRA. 180 Life Sciences received a formal written response on Nov. 23, 2022. The letter noted that the MHRA had reviewed the primary and secondary endpoints in the Repurposing Anti-TNF for Treating Dupuytren’s Disease (“RIDD”) trial and the data provided by the company and concluded that it has not been shown that reducing nodule size via treatment would lead to improvements in terms of disease progression; the letter requested support for a correlation with clinical outcomes, along with other key support information. 180 Life Science is working to provide that information to MHRA. “Based on the advice of our consultants, the company is planning to prepare a MAA with the aim to submit to the MHRA during 2023,” said 180 Life Sciences CEO Dr. James Woody in the press release. “We see this as the continuation of our clinical and regulatory plan to address the huge unmet medical needs of patients with progressive early-stage Dupuytren’s disease, which affects approximately 4% of the Western population.”

To view the full press release, visit https://ibn.fm/5v4wZ

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork